Teva Pharmaceuticals Competitors and Similar CompaniesClear all
Teva Pharmaceuticals's competitors and similar companies include WuXi AppTec, Novartis, AstraZeneca and Roche.
 WuXi AppTec WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. | |||
Founding Date | Founding Date 1901 | Founding Date 2000 | Founding Date 1996 | Founding Date 1999 | Founding Date 1896 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more | Locations Shanghai, CN HQ Beijing, CN Changzhou, CN Chengdu, CN Nanjing, CN Nantong, CN Shanghai, CN see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | |
Employees | Employees 37,000 | Employees 39,414 | Employees 75,883 | Employees 94,300 | Employees 103,249 |
Valuation ($) | Valuation ($) 20.8 b | Valuation ($) 20.7 b | Valuation ($) N/A | Valuation ($) 2.7 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $17.3b (FY, 2025) | Revenue (est.) ¥43.1b (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) CHF61.5b (FY, 2025) |
Cost of goods | Cost of goods $8.3b (FY, 2025) | Cost of goods ¥23.8b (FY, 2025) | Cost of goods $8.4b (FY, 2025) | Cost of goods $4.9b (FY, 2025) | Cost of goods CHF13.1b (FY, 2025) |
Gross profit | Gross profit $8.9b (FY, 2025) | Gross profit ¥21.3b (FY, 2025) | Gross profit $49.8b (FY, 2025) | Gross profit $54.2b (FY, 2025) | Gross profit CHF50.5b (FY, 2025) |
Net income | Net income $1.4b (FY, 2025) | Net income ¥19.3b (FY, 2025) | Net income $14b (FY, 2025) | Net income $10.2b (FY, 2025) | Net income CHF13.8b (FY, 2025) |
Operating ⚠ | |||||
Patients | Patients N/A | Patients N/A | Patients 10 m (FY, 2022) | Patients N/A | Patients 22.8 m (FY, 2023) |
Funding | |||||
Total funding raised | Total funding raised $ 358m | Total funding raised $ 902.6m | Total funding raised $ 6.5m | Total funding raised $ 1b | Total funding raised $ 7.8b |
For sources of this data, please see the company profile
View Company Profiles
WuXi AppTec
HQ
Shanghai, CN
Employees
39,414
WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production.
View companyNovartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyAstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View company
Roche
HQ
Basel, CH
Employees
103,249
Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.
View company